AAAAAA

   
Results: 1-9 |
Results: 9

Authors: ALVARO F TOOGOOD I FLETCHER JM CLEMENTS P RAWLING T TO B
Citation: F. Alvaro et al., ALLOGENEIC CD34 SELECTED PERIPHERAL STEM-CELL TRANSPLANT FOR MAROTEAUX-LAMY-SYNDROME (MUCOPOLYSACCHARIDOSIS TYPE VI) - RAPID HEMATOPOIETIC AND BIOCHEMICAL RECONSTITUTION, Bone marrow transplantation, 21(4), 1998, pp. 419-421

Authors: BEGLEY CG BASSER R MANSFIELD R THOMSON B PARKER WRL LAYTON J TO B CEBON J SHERIDAN WP FOX RM GREEN MD
Citation: Cg. Begley et al., ENHANCED LEVELS AND ENHANCED CLONOGENIC CAPACITY OF BLOOD PROGENITOR CELLS FOLLOWING ADMINISTRATION OF STEM-CELL FACTOR PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR TO HUMANS, Blood, 90(9), 1997, pp. 3378-3389

Authors: KAN M WANG F KAN M TO B GABRIEL JL MCKEEHAN WL
Citation: M. Kan et al., DIVALENT-CATIONS COOPERATE WITH HEPARIN OR HEPARAN-SULFATE TO REGULATE ASSEMBLY OF THE FIBROBLAST GROWTH-FACTOR RECEPTOR COMPLEX, Molecular biology of the cell, 7, 1996, pp. 1074-1074

Authors: HAWKINS T HORVATH N RAWLING C BAYLY J ANDARY C DYSON P HO J DART G JUTTNER C TO B
Citation: T. Hawkins et al., AN INCREMENTAL RESPONSE TO HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA, Bone marrow transplantation, 17(6), 1996, pp. 929-935

Authors: KAN M WANG F KAN M TO B GABRIEL JL MCKEEHAN WL
Citation: M. Kan et al., DIVALENT-CATIONS AND HEPARIN HEPARAN SULFATE COOPERATE TO CONTROL ASSEMBLY AND ACTIVITY OF THE FIBROBLAST GROWTH-FACTOR RECEPTOR COMPLEX/, The Journal of biological chemistry, 271(42), 1996, pp. 26143-26148

Authors: BARDY P WATSON P KAUR P POPPEMA S BOURQUE W TO B SMITH C EMERMAN J EAVES CJ LANSDORP PM
Citation: P. Bardy et al., CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO EPITHELIAL ANTIGENS EXPRESSED ON BREAST-CANCER CELLS AND ABSENT ON HEMATOPOIETIC-CELLS, Blood, 86(10), 1995, pp. 920-920

Authors: BASSER R BEGLEY CG MANSFIELD R TO B JUTTNER C MAHER D FOX R CEBON J SZER J GRIGG A CLARK K MARTY J MENCHACA D THOMPSON B RUSSELL I COLLINS J GREEN M
Citation: R. Basser et al., MOBILIZATION OF PBPC BY PRIMING WITH STEM-CELL FACTOR (SCF) BEFORE FILGRASTIM COMPARED TO CONCURRENT ADMINISTRATION, Blood, 86(10), 1995, pp. 2734-2734

Authors: BEGLEY CG BASSER R MANSFIELD R MAHER D TO B JUTTNER C FOX R CEBON J GRIGG A SZER J MCGRATH K THOMSON B SHERIDAN W MENCHACA D COLLINS J RUSSELL I GREEN M
Citation: Cg. Begley et al., RANDOMIZED PROSPECTIVE-STUDY DEMONSTRATING A PROLONGED EFFECT OF SCF WITH G-CSF(FILGRASTIM) ON PBPC IN UNTREATED PATIENTS - EARLY RESULTS, Blood, 84(10), 1994, pp. 10000025-10000025

Authors: BASSER R TO B GREEN M SZER J BAYLY J DUGGAN G BEGLEY G DYSON P FOX R COLLINS J RUSSELL I MAHER D CEBON J MARTY J JUTTNER C DZIEM G HOFFMAN E SHERIDAN W
Citation: R. Basser et al., RAPID HEMATOPOIETIC RECONSTITUTION FOLLOWING 3 CYCLES OF HIGH-DOSE CHEMOTHERAPY WITH FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND FILGRASTIM IN PATIENTS WITH HIGH-RISK BREAST-CANCER, Blood, 82(10), 1993, pp. 10000233-10000233
Risultati: 1-9 |